Trials / Conditions / Leptomeningeal Neoplasm
Leptomeningeal Neoplasm
3 registered clinical trials studyying Leptomeningeal Neoplasm — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-s NCT04250545 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology NCT04988009 | M.D. Anderson Cancer Center | — |
| Recruiting | Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease NCT03025256 | M.D. Anderson Cancer Center | Phase 1 |